mRNA |
AZD1480 |
CTRPv2 |
pan-cancer |
AAC |
-0.13 |
0.02 |
mRNA |
BRD-K48334597 |
CTRPv2 |
pan-cancer |
AAC |
0.15 |
0.03 |
mRNA |
BRD-K70511574 |
CTRPv2 |
pan-cancer |
AAC |
0.073 |
0.03 |
mRNA |
BCL-LZH-4 |
CTRPv2 |
pan-cancer |
AAC |
0.12 |
0.03 |
mRNA |
Methotrexate |
CTRPv2 |
pan-cancer |
AAC |
0.083 |
0.03 |
mRNA |
BRD-A02303741:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.081 |
0.03 |
mRNA |
COL-3 |
CTRPv2 |
pan-cancer |
AAC |
0.085 |
0.03 |
mRNA |
tanespimycin:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.082 |
0.04 |
mRNA |
SCH-79797 |
CTRPv2 |
pan-cancer |
AAC |
0.076 |
0.04 |
mRNA |
SCH-529074 |
CTRPv2 |
pan-cancer |
AAC |
0.08 |
0.04 |